secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001601485-26-000032
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics enters $100M ATM facility; terminates prior $40M JonesTrading ATM
--------------------------------------------------------------------------------

- Company entered ATM sales agreement to sell up to $100M of common stock through B. Riley Securities, JonesTrading, and Ladenburg Thalmann.
- Agents will receive 3% commission on gross proceeds from any shares sold under the program.
- Company terminated prior $40M ATM agreement with JonesTrading from June 2024, effective immediately.
- Sales will be made at-the-market on Nasdaq under existing S-3 registration statement.
- Company not obligated to sell any shares; program provides capital raising flexibility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148526000032/0001601485-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148526000032/angn-20260316.htm
  HTML page:      https://secwatch.observer/filing/0001601485-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer